Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Deborah Heros"'
Autor:
Ricardo J. Komotar, Deborah Heros, Andrew A. Maudsley, Mohammed Goryawala, Efrat Saraf-Lavi, Natalia Nagornaya
Publikováno v:
J Neuroimaging
BACKGROUND AND PURPOSE: Mutations in isocitrate dehydrogenase (IDH) have a direct effect on gliomagenesis. The purpose of this study is to quantify differences in brain metabolites due to IDH mutations. METHODS: Magnetic Resonance Spectroscopic Imagi
Autor:
Efrat Saraf-Lavi, Mohammed Goryawala, Ricardo J. Komotar, Andrew A. Maudsley, Deborah Heros, Sulaiman Sheriff
Publikováno v:
Journal of Magnetic Resonance Imaging. 48:1551-1558
BACKGROUND Diffusion kurtosis imaging (DKI) measures have been shown to provide increased sensitivity relative to diffusion tensor imaging (DTI) in detecting pathologies. PURPOSE To compare the sensitivity of DKI-derived kurtosis and diffusion maps f
Publikováno v:
Journal of the Neurological Sciences. 396:33-35
Autor:
Karlo J. Lizarraga, Deborah Heros, Jason Margolesky, Ariana W. Rudnick, Vasu Saini, James E. Hoffman, Joshua Lukas, Aditi Dhir
Publikováno v:
Clinical lymphoma, myelomaleukemia. 20(6)
Publikováno v:
Case Reports in Hematology
Case Reports in Hematology, Vol 2019 (2019)
Case Reports in Hematology, Vol 2019 (2019)
Involvement of the central nervous system by chronic lymphocytic leukemia/small lymphocytic lymphoma is exceedingly rare, and currently no risk factors have been described. We report the case of a patient with concomitant chronic lymphocytic leukemia
Autor:
George J. Kaptain, David Schiff, Nam D. Tran, Alexander Lossos, Ryan Merrell, David W. Macdonald, James Perry, Garth Nicholas, Raphael P. Davis, Karen Fink, J. Bradley Elder, Manmeet Ahluwalia, Tobias Walbert, Michael Salacz, Reid C. Thompson, Fairooz F. Kabbinavar, Jason Heth, Denise Damek, Thian Kheoh, Nina L. Martinez, Timothy F. Cloughesy, Daniela A. Bota, Marshall Pitz, Seema Nagpal, Yaron A. Moshel, Jay-Jiguang Zhu, Do-Hyun Nam, David Picconi, Fabio M. Iwamoto, Clark C. Chen, Nicholas Butowski, Gelareh Zadeh, Joseph Landolfi, Chul-Kee Park, Rohan Ramakrishna, Kevin Petrecca, H. Ian Robins, David Tran, Michael A. Vogelbaum, Steven Brem, Dimitris G. Placantonakis, David Cachia, Chetan Bettegowda, Vivek Mehta, Michael Pearlman, Deborah Heros, Nimish Mohile
Publikováno v:
Neuro Oncol
BACKGROUND Toca 511 (vocimagene amiretrorepvec) is a cancer-selective, retroviral replicating vector encoding a codon optimized, heat stabilized cytosine deaminase that converts Toca FC (extended-release 5-fluorocytosine, 5-FC) into the anticancer ag
Autor:
Cristina Herrera, Carlos Robles, Niramol Savaraj, Deborah Heros, Howard J. Landy, Angela Marini, Arnold M. Markoe, Lynn G. Feun
Publikováno v:
Journal of Neuro-Oncology. 82:177-181
CPT-11 is a potent inhibitor of topoisomerase I and has shown antitumor activity in brain xenografts and in clinical trials in recurrent/progressive malignant glioma. VM-26 and VP-16 are topoisomerase II inhibitors and have also shown activity in pha
Autor:
Roberto C. Heros, Deborah Heros
Publikováno v:
Journal of Neurosurgery. 118:783-785
Autor:
Lode J. Swinnen, Allen Cohn, Mark R. Gilbert, Julia M. Kennedy, Warren Mason, Robert Aiken, Surasak Phuphanich, Deborah Heros, Eric T. Wong, Kurt A. Jaeckle, Dorcas Fulton, Stephen B. Howell, Christy A. Russell, Paul L. Moots, Pamela New, Steven J. O'Day, John Gutheil, Lisa R. Rogers, Said Baidas, Tracy T. Batchelor, Glenn J. Lesser
Publikováno v:
Journal of Neuro-Oncology. 57:231-239
Drugs currently available for intrathecal administration are cleared rapidly from the CSF. DepoCyt is a slow-release formulation of cytarabine that maintains cytotoxic concentrations of free cytarabine in the CSF for >14 days following a single injec
Autor:
Harry S. Greenberg, Marc C. Chamberlain, Joseph H. Allen, Kurt A. Jaeckle, Surasak Phuphanich, Warren P. Mason, Said Baidas, Deborah Heros, M. J. van den Bent, Paul L. Moots, Stephen B. Howell, Eric T. Wong, Lawrence D. Recht, Dorcas Fulton, Robert Aiken, Bernard L. Maria, Pamela New, A. Cohn, Susan LaFollette, S. Z. Gertler, Thomas B. Campbell, Lode J. Swinnen, Michael Glantz, William R. Shapiro, Mark R. Gilbert, Steven J. O'Day, John Gutheil, Christy A. Russell, Wallace Akerley, Lisa R. Rogers, Tracy T. Batchelor, Glenn J. Lesser
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 84(2), 157-163. Nature Publishing Group
British Journal of Cancer, 84(2), 157-163. Nature Publishing Group
DepoCyte is a slow-release formulation of cytarabine designed for intrathecal administration. The goal of this multi-centre cohort study was to determine the safety and efficacy of DepoCyte for the intrathecal treatment of neoplastic meningitis due t